Disparities exist in treatment, survival among black, white men with early stage breast cancer
the ONA take:
In this study, the researchers investigated the disparities between blacks and whites in receipt of treatment for early stage breast cancer in men age 18 to 64 years and men 65 years and older.
The study included 725 non-Hispanic black (black) and 5,247 non-Hispanic white (white) men with a diagnosis of early stage breast cancer from 2004 to 2011 in the National Cancer Data Base.
Receipt of treatment was found to be remarkably similar between blacks and whites in both age groups. In both races, fewer older men received chemotherapy compared with younger men.
Risk of death, however, was higher for the younger black men than the younger white men, but the difference was significantly less after adjustments for covariates. That risk was not significant and not affected by covariates in the groups of older men.
Higher risk of death in black men vs white men is limited to men age 18 to 64 years and became nonsignificant after adjustments for insurance and income.
The researchers conclude that improving access to care is an important factor in reducing the disparities in male breast cancer mortality.
Researchers investigated the disparities between blacks and whites in receipt of treatment for early stage breast cancer.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|